Healthtech Startups

Lubricin (PRG4) is a glycoprotein found naturally in the human body that lubricates and protects tissue surfaces from friction and wear. The company develops recombinant lubricin as a therapeutic agent to address inflammation-related conditions like dry eye and osteoarthritis.

2 investors

Lucent Health provides health benefits administration for self-insured employers, combining claims management with data-driven, human-focused care management to help health plan participants make cost-saving healthcare decisions. The company operates nationwide in the US.

2 investors

Lucentia develops AI software that analyses standard cardiac CT scans to extract additional information about the coronary arteries. The approach is designed to detect signs of heart disease earlier without requiring contrast agents or further scans, using imaging that clinicians already perform routinely.

2 investors

Lucerna Dynamics provides software that identifies injection errors in nuclear medicine procedures, evaluates their impact, and helps reduce error frequency for healthcare teams.

2 investors

Lucidact provides nurse-led remote patient monitoring and virtual care for Medicare and Medicaid patients with chronic conditions such as hypertension, heart disease, and diabetes. Its platform supports member enrollment, clinical data monitoring, medication management, care coordination, SDOH screening, and billing for healthcare providers and organizations.

2 investors

Ludocare develops digital therapeutics for pediatric asthma management, combining an interactive health companion app for children with a parental app for monitoring and treatment optimization. The company targets healthcare systems and pediatricians in France seeking to improve asthma control and medication adherence in children ages 4-11.

2 investors

Lully develops an under-mattress device that uses timed vibrations to prevent night terrors in children. The company applies clinical sleep science and user research to create products addressing sleep problems in pediatric populations.

2 investors

Lulo builds a mobile app that helps families access and redeem Supplemental Nutrition Program (WIC) benefits more easily, increasing redemption rates and reducing time spent on WIC shopping. The platform serves low-income families and aims to address food insecurity by unlocking billions in unused government benefits.

2 investors

Lumanity provides consulting services across strategy, evidence generation, stakeholder engagement, and technology and AI to support pharmaceutical and life sciences companies in bringing medicines to patients. It helps clients identify value inflection points to inform strategic decisions in drug development and commercialization.

2 investors

Lumara provides AI agents that automate administrative tasks for healthcare organizations, helping health plans, digital health companies, and other healthcare ecosystem players reduce operational costs while improving member engagement and experience.

2 investors

Lumicell develops a fluorescence-guided intraoperative imaging technology, including its LUMISIGHT optical imaging agent, that illuminates cancerous tissue in the surgical cavity to help surgeons remove residual cancer during procedures such as lumpectomy. The platform is aimed at surgical oncology, starting with breast cancer, and its flagship product has received FDA approval.

2 investors

Luminoah is a medical technology company developing a connected enteral nutrition (tube feeding) system that combines a compact smart pump with a mobile app to track feeding data. Its products serve individuals who rely on tube feeding, along with their caregivers and clinicians.

2 investors

LumiraDx develops rapid point-of-care diagnostic tests run on its microfluidic immunofluorescence platform, including a SARS-CoV-2 antigen test that detects the virus from nasal and nasopharyngeal swab samples in about 12 minutes. The tests are intended for near-patient use by healthcare providers to aid in diagnosing COVID-19 infection.

2 investors

Bright Point Medical develops the BrightPoint needle guidance system, which uses fiber optic light-reflectance sensing to give physicians real-time visual confirmation of tissue at the needle tip during spinal epidural procedures. The device is intended for use in childbirth epidurals, surgical anesthesia, joint injections, and pain management, serving anesthesiologists and other clinicians.

2 investors

Lumos Pharma is a clinical-stage biopharmaceutical company developing therapies for rare diseases, with a lead candidate targeting Pediatric Growth Hormone Deficiency. It also pursues partnerships to in-license or acquire additional rare disease therapeutic candidates for development and commercialization.

2 investors

Lumov Health designs and sells orthopedic support products such as knee braces, insoles, lumbo sacral belts, and compression stockings, developed with orthopedic doctors and tailored to Indian anatomy and weather conditions.

2 investors

Luna is a home-based physical therapy service that connects patients with licensed physical therapists for in-person treatment at their home or workplace, supported by an app for exercise prescription and communication between sessions.

2 investors

Luna Family Autism provides fully virtual, parent-led ABA (Applied Behavior Analysis) therapy for families of children with autism, with programs designed and directed by Master's and PhD-level Board Certified Behavior Analysts. The service is delivered via telehealth to families in several U.S. states, focusing on flexible, family-centered care with reduced weekly time commitment.

2 investors

Lunar builds clinical software that connects tools, data, and workflows used across hospital settings to support clinicians and patient care. It serves healthcare providers and medical centers with mission-critical software spanning multiple disciplines.

2 investors

Lungpacer Medical develops neurostimulation technologies for critical care, focused on ventilator weaning to improve outcomes for patients. Its offerings are built by a team of clinical and engineering experts.

2 investors

LUCK (Love Ur Curls Kids) develops curl care products specifically formulated for babies and children with curly hair, designed to simplify grooming routines and build confidence early. The line includes a 2-in-1 shampoo-conditioner, detangler leave-in conditioner, and baby head-to-toe wash, all dermatologist-tested and hypoallergenic.

2 investors

LUWI is a women-led company developing sexual healthcare products, with a focus on contraception designed around pleasure. Its main product, LUWI Finer Liner, is a hormone-free, latex-free contraceptive intended to prevent STIs while preserving sensation.

2 investors

LVIS provides a cloud-based EEG software platform that enables hospitals to access and collaborate on neurological diagnostic data from multiple EEG systems through a single vendor-agnostic interface, reducing reliance on proprietary local software and IT infrastructure.

2 investors

Lycia Therapeutics is a biotechnology company developing LYTAC (Lysosomal Targeting Chimera) therapeutics that bind disease-causing extracellular and cell-surface proteins and route them into the cell's lysosome for degradation. Its targeted protein degradation platform, based on research from Carolyn Bertozzi's lab at Stanford, aims to address proteins previously considered undruggable.

2 investors